Results: 1-24 |
Results: 24
ABCVEP-I-AND ABCVEP-II COMBINATION CHEMOTHERAPY WITH G-CSF IN PATIENTS WITH AGGRESSIVE LYMPHOMA
Authors: USUI N DOBASHI N KOBAYASHI T NAKAMURA T YAMAZAKI H KAITO H ASAI O FUNAKOSHI S KURAISHI Y
Citation: N. Usui et al., ABCVEP-I-AND ABCVEP-II COMBINATION CHEMOTHERAPY WITH G-CSF IN PATIENTS WITH AGGRESSIVE LYMPHOMA, Blood, 84(10), 1994, pp. 10000650-10000650
ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MURPHY WJ TIAN Z ASAI O HORNUNG R LONGO DL
Citation: Wj. Murphy et al., ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of investigative medicine, 44(3), 1996, pp. 232-232
ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: MURPHY WJ ASAI O TIAN Z HORNUNG R LONGO DL
Citation: Wj. Murphy et al., ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), The FASEB journal, 10(6), 1996, pp. 2509-2509
ADDING BUSULFAN WITH CYCLOPHOSPHAMIDE - TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN FOR ALLOGENEIC TRANSPLANTATION REDUCED RELAPSE RATE IN MYELOID-LEUKEMIA
Authors: ASAI O YANO S KATO A WATANABE H KATORI M NAGAMINE M MAKI N TAJIMA N GOTO S HIRABAYASHI N KURAISHI Y
Citation: O. Asai et al., ADDING BUSULFAN WITH CYCLOPHOSPHAMIDE - TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN FOR ALLOGENEIC TRANSPLANTATION REDUCED RELAPSE RATE IN MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 999-999
ANTITUMOR EFFECTS OF NONCONJUGATED MURINE LYM-2 AND HUMAN-MOUSE CHIMERIC CLL-1 MONOCLONAL-ANTIBODIES AGAINST VARIOUS HUMAN LYMPHOMA CELL-LINES IN-VITRO AND IN-VIVO
Authors: FUNAKOSHI S HIRANO A BECKWITH M ASAI O JORGENSEN G TIAN ZG HORNICK JL HU PS KHAWLI LA EPSTEIN AL LONGO DL MURPHY WJ
Citation: S. Funakoshi et al., ANTITUMOR EFFECTS OF NONCONJUGATED MURINE LYM-2 AND HUMAN-MOUSE CHIMERIC CLL-1 MONOCLONAL-ANTIBODIES AGAINST VARIOUS HUMAN LYMPHOMA CELL-LINES IN-VITRO AND IN-VIVO, Blood, 90(8), 1997, pp. 3160-3166
A PILOT-STUDY OF COMBINATION CHEMOTHERAPY WITH N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP THERAPY) FOR REFRACTORY ADULT ACUTE MYELOGENOUS LEUKEMIA
Authors: DOBASHI N USUI N YAMAZAKI H NAKAMURA T KOBAYASHI T ASAI O KURAISHI Y
Citation: N. Dobashi et al., A PILOT-STUDY OF COMBINATION CHEMOTHERAPY WITH N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP THERAPY) FOR REFRACTORY ADULT ACUTE MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 3010-3010
BEHENOYL CYTARABINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP) - AN EFFECTIVE REGIMEN FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
Authors: DOBASHI N USUI N KOBAYASHI T YAMAZAKI H ASAI O OGIHARA A YANO S KATO A NAGAMINE M SAITO T YAMAGUCHI Y TAJIMA N TAKEI Y KURAISHI Y
Citation: N. Dobashi et al., BEHENOYL CYTARABINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP) - AN EFFECTIVE REGIMEN FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Blood, 90(10), 1997, pp. 2266-2266
CHANGES OF TELOMERE LENGTH AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: AKIYAMA M UCHIYAMA H HOSHI Y YANO S ASAI O KURAISHI Y YAMADA O MIZOGUCHI H YAMADA H
Citation: M. Akiyama et al., CHANGES OF TELOMERE LENGTH AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Experimental hematology, 26(8), 1998, pp. 359-359
CHEMOKINES AND T-LYMPHOCYTE ACTIVATION .2. FACILITATION OF HUMAN T-CELL TRAFFICKING IN SEVERE COMBINED IMMUNODEFICIENCY MICE
Authors: MURPHY WJ TIAN ZG ASAI O FUNAKOSHI S ROTTER P HENRY M STRIETER RM KUNKEL SL LONGO DL TAUB DD
Citation: Wj. Murphy et al., CHEMOKINES AND T-LYMPHOCYTE ACTIVATION .2. FACILITATION OF HUMAN T-CELL TRAFFICKING IN SEVERE COMBINED IMMUNODEFICIENCY MICE, The Journal of immunology, 156(6), 1996, pp. 2104-2111
EFFECTS OF CD40 STIMULATION IN THE PREVENTION OF HUMAN EBV-LYMPHOMAGENESIS
Authors: FUNAKOSHI S TAUB DD ASAI O HIRANO A RUSCETTI FW LONGO DL MURPHY WJ
Citation: S. Funakoshi et al., EFFECTS OF CD40 STIMULATION IN THE PREVENTION OF HUMAN EBV-LYMPHOMAGENESIS, Leukemia & lymphoma, 24(3-4), 1997, pp. 187
EFFECTS OF CD40 STIMULATION ON HUMAN AND MURINE HEMATOPOIESIS
Authors: HIRANO A ASAI O FUNAKOSHI S LONGO D MURPHY W
Citation: A. Hirano et al., EFFECTS OF CD40 STIMULATION ON HUMAN AND MURINE HEMATOPOIESIS, Blood, 88(10), 1996, pp. 1370-1370
IMMUNOLOGICAL AND HEMATOPOIETIC EFFECTS OF CD40 STIMULATION AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION IN MICE
Authors: FUNAKOSHI S TAUB DD ANVER MR RAZIUDDIN A ASAI O REDDY V RAGER H FANSLOW WC LONGO DL MURPHY WJ
Citation: S. Funakoshi et al., IMMUNOLOGICAL AND HEMATOPOIETIC EFFECTS OF CD40 STIMULATION AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION IN MICE, The Journal of clinical investigation, 99(3), 1997, pp. 484-491
INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL TOLERANCE THROUGH THE TREATMENT OF HUMAN T-LYMPHOCYTES WITH WORTMANNIN
Authors: TAUB DD MURPHY WJ ASAI O FENTON RG PELTZ G KEY ML TURCOVSKICORRALES S LONGO DL
Citation: Dd. Taub et al., INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL TOLERANCE THROUGH THE TREATMENT OF HUMAN T-LYMPHOCYTES WITH WORTMANNIN, The Journal of immunology, 158(6), 1997, pp. 2745-2755
INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY CD40 STIMULATION IN-VIVO - A COMPARISON OF A CD40 ANTIBODY AND A RECOMBINANT SOLUBLE CD40 LIGAND (SRCD40L)
Authors: MURPHY WJ ASAI O HIRANO A FUNAKOSHI S FANSLOW WC LONGO DL
Citation: Wj. Murphy et al., INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY CD40 STIMULATION IN-VIVO - A COMPARISON OF A CD40 ANTIBODY AND A RECOMBINANT SOLUBLE CD40 LIGAND (SRCD40L), Blood, 88(10), 1996, pp. 343-343
INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT HUMAN CD40 LIGAND
Authors: FUNAKOSHI S LONGO DL ASAI O BECKWITH M KLINKE R FANSLOW WC MURPHY WJ
Citation: S. Funakoshi et al., INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT HUMAN CD40 LIGAND, Blood, 86(10), 1995, pp. 2397-2397
INHIBITION OF MURINE B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT MURINE CD40 LIGAND
Authors: ASAI O FUNAKOSHI S BECKWITH M FANSLOW W LONGO DL MURPHY WJ
Citation: O. Asai et al., INHIBITION OF MURINE B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT MURINE CD40 LIGAND, The FASEB journal, 10(6), 1996, pp. 944-944
IN-VIVO ANTITUMOR EFFECTS OF UNCONJUGATED CD30 MONOCLONAL-ANTIBODIES ON HUMAN ANAPLASTIC LARGE-CELL LYMPHOMA XENOGRAFTS
Authors: TIAN ZG LONGO DL FUNAKOSHI S ASAI O FERRIS DK WIDMER M MURPHY WJ
Citation: Zg. Tian et al., IN-VIVO ANTITUMOR EFFECTS OF UNCONJUGATED CD30 MONOCLONAL-ANTIBODIES ON HUMAN ANAPLASTIC LARGE-CELL LYMPHOMA XENOGRAFTS, Cancer research, 55(22), 1995, pp. 5335-5341
LOW-TEMPERATURE SYNTHESIS OF CRYSTALLIZED CA1-XSRXTIO3 SOLID-SOLUTIONFILMS ON TITANIUM SUBSTRATES BY A MODIFIED HYDROTHERMAL-ELECTROCHEMICAL TECHNIQUE
Authors: YOSHIMURA M ASAI O CHO WS YASHIMA M SUZUKI Y KAKIHANA M
Citation: M. Yoshimura et al., LOW-TEMPERATURE SYNTHESIS OF CRYSTALLIZED CA1-XSRXTIO3 SOLID-SOLUTIONFILMS ON TITANIUM SUBSTRATES BY A MODIFIED HYDROTHERMAL-ELECTROCHEMICAL TECHNIQUE, Journal of alloys and compounds, 265(1-2), 1998, pp. 132-136
ORAL ETOPOSIDE IN COMBINATION WITH DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (AVEP) IN THE TREATMENT OF NON-HODGKINS-LYMPHOMAS
Authors: KURAISHI Y DOBASHI N USUI N YAMAZAKI H ASAI O KAITO H FUJII T OGASAWARA H KISHI T YAMAGUCHI K TAJIMA N KOBAYASHI T
Citation: Y. Kuraishi et al., ORAL ETOPOSIDE IN COMBINATION WITH DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (AVEP) IN THE TREATMENT OF NON-HODGKINS-LYMPHOMAS, Blood, 90(10), 1997, pp. 855-855
PREDEPOSIT AUTOLOGOUS BLOOD-TRANSFUSION IN INFANTS AND CHILDREN
Authors: HOSHI Y MAKI N ASAI O
Citation: Y. Hoshi et al., PREDEPOSIT AUTOLOGOUS BLOOD-TRANSFUSION IN INFANTS AND CHILDREN, Transfusion, 37(9), 1997, pp. 262-262
PREVENTION OF GRAFT-VERSUS-HOST DISEASE BY IL-2 ACTIVATED DONOR NK CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, ROLE OF IL-2
Authors: ASAI O LONGO DL RUSCETTI FW MURPHY WJ
Citation: O. Asai et al., PREVENTION OF GRAFT-VERSUS-HOST DISEASE BY IL-2 ACTIVATED DONOR NK CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, ROLE OF IL-2, Blood, 88(10), 1996, pp. 978-978
PROGNOSTIC-SIGNIFICANCE OF AGE AND CYTOGENETICS IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: USUI N DOBASHI N KATO A MAKI N ASAI O KOBAYASHI T TAJIMA N KURAISHI Y
Citation: N. Usui et al., PROGNOSTIC-SIGNIFICANCE OF AGE AND CYTOGENETICS IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 3798-3798
ROLE OF DAUNORUBICIN IN THE INDUCTION THERAPY FOR ADULT ACUTE MYELOID-LEUKEMIA
Authors: USUI N DOBASHI N KOBAYASHI T YANO S MAKI N ASAI O SAITO T YAMAGUCHI Y WATANABE H KATO A OGIHARA A KATORI M NAGAMINE M TAKEI Y YAMAZAKI H FUNAKOSHI S TAJIMA N OGAWA M KURAISHI Y
Citation: N. Usui et al., ROLE OF DAUNORUBICIN IN THE INDUCTION THERAPY FOR ADULT ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 16(6), 1998, pp. 2086-2092
SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE AND AMPLIFICATION OF GRAFT-VERSUS-TUMOR EFFECTS BY ACTIVATED NATURAL-KILLER-CELLS AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION
Authors: ASAI O LONGO DL TIAN ZG HORNUNG RL TAUB DD RUSCETTI FW MURPHY WJ
Citation: O. Asai et al., SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE AND AMPLIFICATION OF GRAFT-VERSUS-TUMOR EFFECTS BY ACTIVATED NATURAL-KILLER-CELLS AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION, The Journal of clinical investigation, 101(9), 1998, pp. 1835-1842
Risultati: 1-24 |